List of works by Roberto Ronca

A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.

scientific article

Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.

scientific article

Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists

scientific article

Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.

scientific article

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

scientific article published on 21 March 2016

Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation

scientific article published on 13 February 2019

Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma

scientific article

Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer

scientific article published on 22 October 2018

Circulating microRNAs and Their Role in Multiple Myeloma

scientific article published on 02 May 2019

Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis

scientific article published on 7 August 2017

Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.

scientific article published on 21 July 2009

Dendritic cells in inflammatory angiogenesis and lymphangiogenesis

scientific article published on 04 June 2018

Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole

scientific article published on 24 May 2016

Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.

scientific article published on 26 March 2015

Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis

scientific article published on June 2003

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer

scientific article published in August 2017

Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development

scientific article

Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development

scientific article published on 31 July 2003

Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells

scientific article published on 22 June 2009

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

scientific article

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach

scientific article published on 28 May 2017

Future applications of FGF/FGFR inhibitors in cancer

scientific article published on 02 July 2018

Gene expression profile in fibroblast growth factor 2-transformed endothelial cells

scientific article published on April 2002

HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.

scientific article published on 8 February 2016

Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice

scientific article published in December 2009

Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies

scientific article published in Nature Communications

Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

scientific article published on 13 January 2017

Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.

scientific article published on June 2009

Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

scientific article published on September 2013

Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress

scientific article published on 09 December 2020

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression

scientific article published on 30 August 2019

Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis

scientific journal article

Long pentraxin 3: A novel multifaceted player in cancer

scientific article published on 23 November 2017

Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.

scientific article published on June 2013

Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.

scientific article

Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.

scientific article published on 15 October 2013

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy

scientific journal article

Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease

scientific article published on 24 January 2014

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist

scientific article published on 11 May 2016

Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue

scientific article published on 18 November 2019

PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma

scientific article published on 17 September 2019

Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes.

scientific article published on 27 October 2017

Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics

scientific article

Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents

scientific article

Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.

scientific article

The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.

scientific article

The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.

scientific article published on March 2015

The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.

scientific article published on 30 June 2015

Tumor angiogenesis revisited: Regulators and clinical implications.

scientific article

U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.

scientific article

Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis

scientific article published on 15 June 2018

Vascular disrupting activity of combretastatin analogues

scientific article published on 25 May 2016